A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory

Scale Media Inc

Status: Active, not recruiting

Conditions: Cognitive Function; Cognitive Decline

Treatments: Dietary Supplement: MindMD Supplement; Other: Placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT06523218

20429

Details and patient eligibility

About

This study will evaluate the efficacy of 1MD Nutrition's MindMD supplement in improving and maintaining cognitive function and memory. The randomized controlled trial will include 50 healthy participants aged 50-75 years, lasting for 3 months. Participants will be randomized to receive either the test product or a placebo.

Enrollment: 50 estimated patients

Sex: All

Ages: 50 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 50-75 years
• Regular experience of symptoms related to cognitive decline (e.g., forgetfulness, lack of focus, brain fog)
• Generally healthy without uncontrolled chronic diseases
• Willingness to avoid certain medications and supplements during the study

Exclusion criteria

• Any medical condition or treatment impacting cognitive ability Mental health or neurological disorders
• Severe allergies, particularly to soy or other product ingredients
• Taking blood thinning medication
• Recent or planned surgeries
• Major illness in the past three months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

50 participants in 2 patient groups, including a placebo group

MindMD Supplement

Experimental group

Description:

Participants in the experimental group will receive the MindMD supplement, which contains the following ingredients: 600 mg Bacopa monnieri (Bacognize®), 250 mg Cognigrape® Grape Extract, 100 mg Phosphatidylserine, 50 mg Green Tea Leaf Extract, 1.7 mg Vitamin B6, and 200 mcg Folate (120 mcg folic acid).

Treatment:

Dietary Supplement: MindMD Supplement

Placebo

Placebo Comparator group

Description:

Participants in the placebo group will receive a placebo, which contains rice flour encapsulated in a vegetable cellulose capsule.

Treatment:

Other: Placebo